These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 30653950)
1. Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells. Rudin D; Lanzilotto A; Bachmann F; Housecroft CE; Constable EC; Drewe J; Haschke M; Krähenbühl S Biochem Pharmacol; 2019 May; 163():345-356. PubMed ID: 30653950 [TBL] [Abstract][Full Text] [Related]
2. Toxicity of metamizole on differentiating HL60 cells and human neutrophil granulocytes. Rudin D; Roos NJ; Duthaler U; Krähenbühl S Toxicology; 2019 Oct; 426():152254. PubMed ID: 31356851 [TBL] [Abstract][Full Text] [Related]
3. Reactive Metamizole Metabolites Enhance the Toxicity of Hemin on the ATP Pool in HL60 Cells by Inhibition of Glycolysis. Rudin D; Schmutz M; Roos NJ; Bouitbir J; Krähenbühl S Biomedicines; 2020 Jul; 8(7):. PubMed ID: 32674331 [TBL] [Abstract][Full Text] [Related]
4. N-demethylation of N-methyl-4-aminoantipyrine, the main metabolite of metamizole. Bachmann F; Duthaler U; Rudin D; Krähenbühl S; Haschke M Eur J Pharm Sci; 2018 Jul; 120():172-180. PubMed ID: 29746911 [TBL] [Abstract][Full Text] [Related]
5. NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis. Radulovic I; Dogan B; Dohna-Schwake C; Schündeln MM; Siffert W; Möhlendick B Pharmacogenet Genomics; 2021 Aug; 31(6):140-143. PubMed ID: 33675325 [TBL] [Abstract][Full Text] [Related]
6. Effect of metamizol on promyelocytic and terminally differentiated granulocytic cells. Comparative analysis with acetylsalicylic acid and diclofenac. García-Martínez JM; Fresno Vara JA; Lastres P; Bernabéu C; Betés PO; Martín-Pérez J Biochem Pharmacol; 2003 Jan; 65(2):209-17. PubMed ID: 12504796 [TBL] [Abstract][Full Text] [Related]
7. Plasma protein binding of dipyrone metabolites in man. Zylber-Katz E; Granit L; Levy M Eur J Clin Pharmacol; 1985; 29(1):67-71. PubMed ID: 4054207 [TBL] [Abstract][Full Text] [Related]
8. Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole. Ariza A; García-Martín E; Salas M; Montañez MI; Mayorga C; Blanca-Lopez N; Andreu I; Perkins J; Blanca M; Agúndez JA; Torres MJ Sci Rep; 2016 Mar; 6():23845. PubMed ID: 27030298 [TBL] [Abstract][Full Text] [Related]
9. Photodegradation study of three dipyrone metabolites in various water systems: identification and toxicity of their photodegradation products. Gómez MJ; Sirtori C; Mezcua M; Fernández-Alba AR; Agüera A Water Res; 2008 May; 42(10-11):2698-706. PubMed ID: 18294672 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profiles of the active metamizole metabolites in healthy horses. Giorgi M; Aupanun S; Lee HK; Poapolathep A; Rychshanova R; Vullo C; Faillace V; Laus F J Vet Pharmacol Ther; 2017 Apr; 40(2):165-171. PubMed ID: 27477925 [TBL] [Abstract][Full Text] [Related]
11. Effects of metamizole, MAA, and paracetamol on proliferation, apoptosis, and necrosis in the pancreatic cancer cell lines PaTu 8988 t and Panc-1. Malsy M; Graf B; Bundscherer A BMC Pharmacol Toxicol; 2017 Dec; 18(1):77. PubMed ID: 29208039 [TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4-methylaminoantipyrine. Bachmann F; Meyer Zu Schwabedissen HE; Duthaler U; Krähenbühl S Br J Clin Pharmacol; 2022 Feb; 88(4):1885-1896. PubMed ID: 34648192 [TBL] [Abstract][Full Text] [Related]
13. Acute Liver Failure in a Patient Treated With Metamizole. Krisai P; Rudin D; Grünig D; Scherer K; Pichler W; Terracciano L; Krähenbühl S Front Pharmacol; 2019; 10():996. PubMed ID: 31572180 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic properties of metamizole active metabolites in Northeastern Brazilian donkeys (Equus asinus). de Macêdo LB; Mouta AN; Araújo-Silva G; Urizar JTP; de Paula VV J Vet Pharmacol Ther; 2021 Sep; 44(5):842-849. PubMed ID: 34268764 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic profiles of the active metamizole metabolites after four different routes of administration in healthy dogs. Giorgi M; Łebkowska-Wieruszewska B; Lisowski A; Owen H; Poapolathep A; Kim TW; De Vito V J Vet Pharmacol Ther; 2018 Jun; 41(3):428-436. PubMed ID: 29352476 [TBL] [Abstract][Full Text] [Related]
16. The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: neuronal K(ATP) channel opening and CB(1) receptor activation. dos Santos GG; Dias EV; Teixeira JM; Athie MC; Bonet IJ; Tambeli CH; Parada CA Eur J Pharmacol; 2014 Oct; 741():124-31. PubMed ID: 25058903 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profiles of the two major active metabolites of metamizole, 4-methylaminoantipyrine (MAA) and 4-aminoantipyrine (AA), after intravenous injection in cats. de Paula VV; Araújo-Silva G; Fernandes NS; Mouta AN; Nunes TL; de Paiva ALC; de Macêdo LB; Arcoverde KN; Urizar JTP Res Vet Sci; 2023 Feb; 155():156-160. PubMed ID: 36701839 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone. Cohen O; Zylber-Katz E; Caraco Y; Granit L; Levy M Eur J Clin Pharmacol; 1998 Sep; 54(7):549-53. PubMed ID: 9832297 [TBL] [Abstract][Full Text] [Related]
19. Excretion of dipyrone metabolites in human breast milk. Zylber-Katz E; Linder N; Granit L; Levy M Eur J Clin Pharmacol; 1986; 30(3):359-61. PubMed ID: 3732376 [TBL] [Abstract][Full Text] [Related]
20. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data. Klose S; Pflock R; König IR; Linder R; Schwaninger M Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]